Caitong International Asset Management’s Checkpoint Therapeutics CKPT Stock Holding History

Caitong International Asset Management’s Portfolio CKPT Stock Details CKPT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-2,999	Closed	-$12.1K	–	2067
2025 Q1	$12.1K	Buy	+2,999	New	+$10K	0.01%	833

Caitong International Asset Management's CKPT Position: Q2 2025 in Review

Caitong International Asset Management sold out of Checkpoint Therapeutics (CKPT) in Q2 2025, closing a stake of 2,999 shares — an estimated $12.1K sold.

Caitong International Asset Management first reported a position in CKPT in Q1 2025 and held it in 1 quarter. The position peaked at $12.1K in Q1 2025. 0 funds tracked by Wall St. Rank hold CKPT as of Q2 2025.

Caitong International Asset Management reported no remaining Checkpoint Therapeutics position as of Q2 2025 after selling out during the quarter.
Caitong International Asset Management sold 2,999 Checkpoint Therapeutics shares in Q2 2025, an estimated $12.1K.
Caitong International Asset Management first reported a position in Checkpoint Therapeutics in Q1 2025 and held it in 1 quarter.
Caitong International Asset Management's Checkpoint Therapeutics position peaked at $12.1K in Q1 2025.
0 funds tracked by Wall St. Rank held Checkpoint Therapeutics as of Q2 2025.

Based on Caitong International Asset Management's 13F filing for Q2 2025, filed 31 Jul 2025.